Everyday memory impairment of patients with mild cognitive impairment

Hiroaki Kazui1, Akemi Matsuda, Nobutsugu Hirono

  • 1Psychiatry and Behavioral Science, Osaka University Graduate School of Medicine, Osaka, Japan. kazui@psy.med.osaka-u.ac.jp

Insights

Mild cognitive impairment (MCI) patients show everyday memory deficits, milder than Alzheimer

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychology

Background:

  • Mild cognitive impairment (MCI) represents a transitional stage between normal aging and Alzheimer's disease (AD).
  • Accurate diagnosis of MCI is crucial for timely intervention and management.
  • Everyday memory function is a key indicator of cognitive health and daily functioning.

Purpose of the Study:

  • To evaluate everyday memory impairment in patients with mild cognitive impairment (MCI).
  • To compare the performance of MCI patients on the Rivermead Behavioral Memory Test (RBMT) with normal controls (NC) and Alzheimer's disease (AD) patients.
  • To assess the diagnostic utility of the RBMT in identifying MCI.

Main Methods:

  • The Rivermead Behavioral Memory Test (RBMT) was administered to 24 MCI patients, 48 normal controls (NC), and 48 Alzheimer's disease (AD) patients.
  • Participants were matched for age, sex, and education.
  • Performance on various memory tasks, including delayed recall and route retracing, was analyzed.

Main Results:

  • MCI patients exhibited overall everyday memory impairment, less severe than that observed in AD patients.
  • MCI patients struggled with delayed recall tasks and recalling/retracing a simple new route.
  • Immediate recall performance was generally preserved in MCI patients.
  • The RBMT total Profile score achieved 100% accuracy in classifying MCI patients and 91.7% in classifying NC.
  • Prospective memory tasks did not effectively differentiate MCI patients from controls.

Conclusions:

  • The Rivermead Behavioral Memory Test (RBMT) is a valuable tool for diagnosing mild cognitive impairment (MCI).
  • MCI is characterized by specific deficits in delayed recall and spatial memory tasks.
  • The RBMT's Profile score demonstrates high diagnostic accuracy for MCI, distinguishing it from normal cognition.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Amnesia01:13

Amnesia

Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...